Journal of Nutrition EB Program 2010 Abstracts

Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wallig, M. A.
Right arrow Articles by Gossman, T.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wallig, M. A.
Right arrow Articles by Gossman, T.
© 2005 American Society for Nutrition J. Nutr. 135:2972S-2977S, December 2005


Supplement: International Conference on Diet, Nutrition, and Cancer

Synergy among Phytochemicals within Crucifers: Does It Translate into Chemoprotection?1,2,3

Matthew A. Wallig4, Kathleen M. Heinz-Taheny, Donna L. Epps and Tamara Gossman

Department of Pathobiology, College of Veterinary Medicine, University of Illinois at Urbana-Champaign, Urbana, IL 61802

4To whom correspondence should be addressed. E-mail: mawallig{at}uiuc.edu.

ABSTRACT

The association between cruciferous vegetables and cancer prevention has been linked to glucosinolate derivatives. These phytochemicals enhance endogenous detoxification, leading to inactivation of potential carcinogens before initiation occurs. Two derivatives, indole-3-carbinol (I3C) and 1-cyano-2-hydroxy-3-butene (crambene) were shown in rats to induce a synergistic enhancement of detoxification enzyme activity. To follow up on these findings, a short-term carcinogenicity study using aflatoxin B1 (AFB1) was performed in which male F344 rats were fed diets supplemented with these 2 compounds alone or in combination. Groups included a negative control group (no AFB1, crambene, or I3C), a crambene group (diet 0.150% crambene), an I3C group (diet 0.165% I3C), a high-dose group (diet 0.150% crambene, 0.165% I3C) a low-dose group (diet 0.030% crambene, 0.033% I3C), and a positive control group (AFB1 treatment only). AFB1 was administered after 2 wk of dietary pretreatment. Liver sections were scored for lesions including karyomegaly, apoptosis, and biliary hyperplasia and evaluated for expression of the preneoplastic marker glutathione S-transferase-{pi} (GSTP). I3C and crambene groups were protected against AFB1 toxicity whereas the low-dose group was not. The high-dose group had scores close to those of the negative controls. For log10 transformed 2- and 3-dimensional GSTP data, the high-dose group demonstrated synergistic reduction in GSTP-positive area and an additive reduction in GSTP-positive volume compared with the crambene and I3C groups. The low-dose group had no effect. In conclusion, high combination dietary doses of I3C and crambene demonstrated enhanced protection from AFB1. Low combination doses, as might be realistically in the diet, were not effective.


KEY WORDS: • synergy • phytochemicals • indole-3-carbinol • crambene • aflatoxin B1 • glutathione S-transferase-{pi} • chemoprotection




This article has been cited by other articles:


Home page
CarcinogenesisHome page
G. Pappa, J. Strathmann, M. Lowinger, H. Bartsch, and C. Gerhauser
Quantitative combination effects between sulforaphane and 3,3'-diindolylmethane on proliferation of human colon cancer cells in vitro
Carcinogenesis, July 1, 2007; 28(7): 1471 - 1477.
[Abstract] [Full Text] [PDF]




Home Help [Feedback] [For Subscribers] [Archive] [Search] [Contents]
Copyright © 2005 by American Society for Nutrition